Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases.
CLEVELAND, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced that members of its management team will participate in upcoming investor conferences in...
CLEVELAND, Sept. 02, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive employees who joined the Company. The...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.15 | -2.67857142857 | 5.6 | 5.75 | 5.32 | 146062 | 5.46773627 | CS |
4 | 0.19 | 3.61216730038 | 5.26 | 5.84 | 5.08 | 186496 | 5.54036538 | CS |
12 | 1.39 | 34.236453202 | 4.06 | 5.84 | 4.04 | 294764 | 5.06967986 | CS |
26 | -1.55 | -22.1428571429 | 7 | 8.45 | 3.05 | 510823 | 4.72157921 | CS |
52 | 1.79 | 48.9071038251 | 3.66 | 9.01 | 3.05 | 378996 | 5.0464552 | CS |
156 | 4.25 | 354.166666667 | 1.2 | 9.01 | 0.1303 | 792887 | 1.52974396 | CS |
260 | 2.26 | 70.8463949843 | 3.19 | 9.01 | 0.1303 | 1179244 | 1.93467439 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.